PBN Extra: National fee schedule for drugs unveiled

Why This Topic Matters

Medicare drug payment changes can affect reimbursement, office billing practices, and comparisons across carriers. The article helps readers understand the scope of the national pricing update and the related coding environment without relying on carrier-specific assumptions.

Article Sections

1. National Medicare drug reimbursement schedule

   Overview of the newly released federal payment schedule for physician-administered drugs and the timing of its implementation. Discusses the general pricing approach and the organizations involved.

2. Drugs excluded from the schedule

   General discussion of drug categories that are not included in the list, along with references to related code series and CMS manual guidance.

3. Most utilized Part B drugs and payment comparisons

   Summary of commonly billed office-administered drugs and a comparison of existing carrier payment levels with the new national approach. Focuses on reimbursement changes across carriers.

4. Not otherwise classified drugs and reporting guidance

   Discussion of miscellaneous drug reporting categories, carrier-dependent code selection, and national claims patterns for unclassified drug reporting.

5. New drug codes and future policy activity

   Brief note on code creation tied to product and packaging changes, followed by a broader comment on possible future payment reform activity.